Bosh sahifa068270 • KRX
add
Celltrion Inc
Yopilish kursi
176 000,00 ₩
Kunlik diapazon
173 050,00 ₩ - 176 500,00 ₩
Yillik diapazon
144 615,31 ₩ - 188 800,00 ₩
Bozor kapitalizatsiyasi
40,41 trln KRW
Oʻrtacha hajm
466,80 ming
Narx/foyda
70,90
Dividend daromadliligi
0,39%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 961,46 mlrd | 9,91% |
Joriy xarajat | 301,28 mlrd | 2,01% |
Sof foyda | 61,17 mlrd | -21,59% |
Sof foyda marjasi | 6,36 | -28,70% |
Har bir ulushga tushum | 276,00 | -20,06% |
EBITDA | 319,79 mlrd | 56,22% |
Amaldagi soliq stavkasi | -20,74% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 824,00 mlrd | -20,06% |
Jami aktivlari | 20,55 trln | 2,10% |
Jami passivlari | 3,89 trln | 24,20% |
Umumiy kapital | 16,66 trln | — |
Tarqatilgan aksiyalar | 220,28 mln | — |
Narxi/balansdagi bahosi | 2,35 | — |
Aktivlardan daromad | 2,93% | — |
Kapitaldan daromad | 3,14% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 61,17 mlrd | -21,59% |
Operatsiyalardan naqd pul | 188,14 mlrd | -35,92% |
Sarmoyadan naqd pul | -115,46 mlrd | -211,15% |
Moliyadan naqd pul | -196,36 mlrd | 20,36% |
Naqd pulning sof oʻzgarishi | -178,62 mlrd | -213,72% |
Boʻsh pul | 92,77 mlrd | -9,21% |
Haqida
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Tashkil etilgan
2002
Sayt
Xodimlar soni
2 680
